Research Summary

My non-clinical work focuses on developing and evaluating risk assessment tools for breast cancer and using those tools to efficiently use screening technologies and preventive therapies to decrease the burden of breast cancer in our community.

I also perform technology assessments and support cost-effectiveness modeling and budget impact analyses for new medications, medical devices, and health system interventions for the Institute for Clinical and Economic Review.

Education

Dartmouth College, Hanover, NH, BA, 06/1983, Math; Philosophy
San Francisco State University, 05/1989, Pre-medical classed
University of California, San Francisco, MD, 06/1994, Medicine
University of California, San Francisco, 06/1997, Internal Medicine
University of California, San Francisco, Postdoctoral, 06/1999, Research/Epidmiology

Honors & Awards

  • 2013
    UCSF Research Mentoring Award
  • 2009
    Society of General Internal Medicine- CA Region- Outstanding Clinician Investigator Award
  • 2003
    Robert Crede Award for Clinical Research, UCSF Division of General Internal Medicine
  • 2002-2004
    Building Interdisciplinary Research Careers in Women's Health (BIRCWH) Faculty Scholar
  • 1994
    Alpha Omega Alpha, UCSF
  • 1990-1994
    Regents Scholarship, UCSF
  • 1983
    Summa Cum Laude, Dartmouth College
  • 1982
    Phi Beta Kappa, Dartmouth College
  • 1979-1983
    Rufous Choate Scholar, Dartmouth College
  • 1979-1983
    IBM Thomas J. Watson Scholar

Selected Publications

  1. Qaseem A, Fitterman N, Tierney S, Powell RE, Campos K, Choi EI, Crandall CJ, Cross JT, Humphrey LL, Obley AJ, Wilt TJ, Andrews RA, Performance Measurement Committee and the Clinical Guidelines Committee of the American College of P, Basch P, Khetan RS, MacDonald ST, Miller NL, Mount CA, Watts B, Balk EM, Cooney TG, Lewis J, Maroto M, Miller MC, Owens DK, Tice JA, Harrod CS, Pardo-Hernández H, Shamliyan T Identifying Core Clinical Topics and Recommending Core Performance Measures for Internal Medicine Physicians: A Position Paper From the American College of Physicians.  View on PubMed
  2. Fergus KB, Heise RS, Madlensky L, Fiscalini A, Sabacan L, Theiner S, Kapoor S, Soto IA, Blanco A, Ross K, Goodman-Gruen D, Scheuner M, Hu D, Heditsian D, Brain S, Arasu VA, Kaster A, Chapa L, Olopade OI, Eklund M, Tice JA, Ziv E, van 't Veer L, Esserman LJ, Shieh Y, Athena/WISDOM Network Collaborators and Advocate Partners Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial.  View on PubMed
  3. Qaseem A, Owens DK, Etxeandia-Ikobaltzeta I, Cross JT, Yost J, Crandall CJ, and the Clinical Guidelines Committee of the American College of Physicians*, Balk EM, Fitterman N, Gibson M, Lewis J, Miller MC, Obley AJ, Schmidt KA, Shekelle PG, Tice JA, Carroll K, Harrod CS, Shamliyan T, Vigna C, Clinical Guidelines Committee of the American College of Physicians Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert 3).  View on PubMed
  4. Kerlikowske K, Abraham L, Sprague BL, Sattayapiwat O, Nyante SJ, Tice JA, Miglioretti DL Mammographic calcifications association with risk of advanced breast cancer.  View on PubMed
  5. Kerlikowske K, Tice JA. Digital Breast Tomosynthesis and Digital Mammography Associated with Similar Rates of Advanced Cancer. Radiology. 2025 May; 315(2):e242837.  View on PubMed
  6. Qaseem A, Tice JA, Etxeandia-Ikobaltzeta I, Wilt TJ, Harrod CS, Cooney TG, Crandall CJ, Clinical Guidelines Committee of the American College of Physicians, Hicks LA, Balk E, Cross JT, Fitterman N, Lewis J, Linsky AM, Maroto M, Miller MC, Obley AJ, Owens DK, Shekelle PG, Shamliyan T, Yost J. Pharmacologic Treatments of Acute Episodic Migraine Headache in Outpatient Settings: A Clinical Guideline From the American College of Physicians. Ann Intern Med. 2025 Apr; 178(4):571-578.  View on PubMed
  7. Badal K, Staib J, Tice JA, Kim MO, Eklund M, Wilson L, Dacosta Byfield S, Catlett K, Maffey L, Soonavala R, Shieh Y, Esserman LJ. National yearly cost of breast cancer screening in the USA and projected cost of advocated guidelines: a simulation study with life table modelling. BMJ Open. 2025 Feb 17; 15(2):e089428.  View on PubMed
  8. Qaseem A, Owens DK, Etxeandia-Ikobaltzeta I, Cross JT, Yost J, Crandall CJ, Clinical Guidelines Committee of the American College of Physicians, Crandall CJ, Hicks LA, Balk EM, Cooney TG, Cross JT, Fitterman N, Lewis J, Linsky AM, Maroto M, Miller MC, Obley AJ, Owens DK, Shekelle PG, Tice JA, Etxeandia-Ikobaltzeta I, Harrod CS, Qaseem A, Yost J. Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert 2, Surveillance Note 1). Ann Intern Med. 2025 Mar; 178(3):e2403549.  View on PubMed
  9. Qaseem A, Cooney TG, Shamliyan TA, Yost J, Hicks LA, Clinical Guidelines Committee of the American College of Physicians, Hicks LA, Balk EM, Cooney TG, Cross JT, Fitterman N, Lewis J, Linsky AM, Maroto M, Miller MC, Obley AJ, Owens DK, Shekelle PG, Tice JA, Etxeandia-Ikobaltzeta I, Harrod CS, Qaseem A, Shamliyan TA, Yost J. Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians (Version 1: Update Alert 1: Surveillance Note 1). Ann Intern Med. 2025 Mar; 178(3):e2403547.  View on PubMed
  10. Qaseem A, Cooney TG, Etxeandia-Ikobaltzeta I, Wilt TJ, Harrod CS, Tice JA, Crandall CJ, Clinical Guidelines Committee of the American College of Physicians, Hicks LA, Cross JT, Fitterman N, Lewis J, Linsky AM, Maroto M, Miller MC, Obley AJ, Owens DK, Shekelle PG, Shamliyan T, Yost J. Prevention of Episodic Migraine Headache Using Pharmacologic Treatments in Outpatient Settings: A Clinical Guideline From the American College of Physicians. Ann Intern Med. 2025 Mar; 178(3):426-433.  View on PubMed
  11. Qaseem A, Shamliyan T, Owens DK, Tice JA, Crandall CJ, Clinical Guidelines Committee of the American College of Physicians, Hicks LA, Wilt TJ, Balk EM, Cooney TG, Cross JT, Fitterman N, Lewis J, Lin JS, Linsky A, Maroto M, Miller MC, Obley AJ, Shekelle P, Tufte JE, Etxeandia-Ikobaltzeta I, Harrod CS, Yost J, Qaseem A, Shamliyan T, Crandall CJ, Owens DK, Tice JA. Incorporating Economic Evidence in Clinical Guidelines: A Framework From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2025 Feb; 178(2):241-248.  View on PubMed
  12. Sarker J, Tice JA, Rind DM, Walton SM. Evaluating the Cost-Effectiveness of Etranacogene Dezaparvovec Gene Therapy for Hemophilia B Treatment in the USA. Appl Health Econ Health Policy. 2025 May; 23(3):467-478.  View on PubMed
  13. Fahim SM, Tice JA, Luu L, Carlson JJ, Richardson M, Herce-Hagiwara B, Dickerson R, Ollendorf DA. Imetelstat for anemia in lower-risk myelodysplastic syndromes: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum. J Manag Care Spec Pharm. 2024 Dec; 30(12):1479-1485.  View on PubMed
  14. Kerlikowske K, Esserman L, Tice JA. Screening Mammography for 40-Year-Old Women-Whose Decision? JAMA Intern Med. 2024 Nov 01; 184(11):1281-1282.  View on PubMed
  15. Wright AC, McKenna A, Tice JA, Rind DM, Agboola F. A network meta-analysis of KarXT and commonly used pharmacological interventions for schizophrenia. Schizophr Res. 2024 12; 274:212-219.  View on PubMed
  16. Sarker J, Tice JA, Rind DM, Pearson SD, Walton SM. The impact of capping health system cost savings on the projected cost-effectiveness of etranacogene dezaparvovec compared with factor IX prophylaxis for the treatment of hemophilia B. J Manag Care Spec Pharm. 2024 Aug; 30(8):868-872.  View on PubMed
  17. Richardson M, Wright AC, Tice JA, Rind DM, Seidner M, Emond S, Pearson SD. Informing the United States Medicare Drug Price Negotiation for Apixaban and Rivaroxaban: Methodological Considerations for Value Assessments Many Years After Launch. Value Health. 2024 11; 27(11):1507-1514.  View on PubMed
  18. Qaseem A, Owens DK, Etxeandia-Ikobaltzeta I, Tufte JE, Cross JT, Wilt TJ, Clinical Guidelines Committee for the American College of Physicians, Crandall CJ, Hicks LA, Balk EM, Cooney TG, Fitterman N, Lin JS, Maroto M, Miller MC, Obley AJ, Shekelle PG, Tice JA, Harrod CS, Yost J. Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert 2). Ann Intern Med. 2024 Aug; 177(8):e2400593.  View on PubMed
  19. Lien PW, Joshi M, Tice JA, Agboola F, Nikitin D, Withanawasam V, Jatoi S, Touchette DR. Cost-effectiveness of eculizumab and efgartigimod for the treatment of anti-acetylcholine receptor antibody-positive generalized myasthenia gravis. J Manag Care Spec Pharm. 2024 06; 30(6):517-527.  View on PubMed
  20. McKenna A, Tice JA, Whittington MD, Wright AC, Richardson M, Raymond FR, Pearson SD, Rind DM, Agboola F. KarXT for schizophrenia-effectiveness and value: A summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council. J Manag Care Spec Pharm. 2024 Jun; 30(6):624-628.  View on PubMed

Go to UCSF Profiles, powered by CTSI